Biotechnology Companies in Asia

Prathista Industries Limited is a pioneering Indian multinational company specializing in fermentation technology and committed to the ‘Waste into Wealth’ concept. Based in Secunderabad, India, and with international operations in the USA, Uganda, Panama, and Europe, we manufacture and market a diverse range of eco-friendly biotechnology products, including Bulk Drugs, Organic Plant Nutrients, Crop Protection formulations, Bio Fertilizers, Organic Feed Supplements, Chelated Minerals, and Nutraceutical products. Leveraging our fermentation expertise, we cater to a global market, exporting to 13 countries including the USA, Panama, Netherlands, China, Ghana, Philippines, and Turkey. Our commitment to sustainable agriculture and innovative solutions positions us as a key player in promoting plant-based, non-GMO, and fermentation-based products for food safety and reduced food waste worldwide. With a strong focus on research and development, Prathista Industries delivers tailored formulations and contract manufacturing services, supporting a healthier and more sustainable future for the food and agricultural industries.

myAmalpk is a Digital Cancer Diagnosis Ecosystem based in Islamabad, Pakistan, leveraging Artificial Intelligence to revolutionize cancer detection and prevention.

We provide a cutting-edge digital medical education platform and a highly accurate cancer diagnosis solution, designed to improve patient outcomes and empower healthcare professionals.

myAmalpk’s approach combines advanced AI algorithms with a user-friendly interface, offering accessible and reliable cancer screening. Our focus is on transforming cancer care through innovation and technology, ultimately bringing hope to life.

Founded in 2019, myAmalpk is a rapidly growing company dedicated to advancing cancer diagnostics and improving global health outcomes. We currently operate across Pakistan, the UK, the United States, and Saudi Arabia.

HuidaGene Therapeutics is a global clinical-stage biotechnology company based in Shanghai and New Jersey, dedicated to revolutionizing genomic medicine through the development of CRISPR-based gene editing tools and gene therapies.

We address critical patient needs across ophthalmology, neurology, neuro-myology, and otology, leveraging our HG-AAV Platform and Animal Model Platform to develop innovative therapeutic programs.

HuidaGene distinguishes itself through a robust pipeline focused on diseases like RPE65 Mutation-Associated Inherited Retinal Dystrophies, Huntington's Disease, and ALS, driven by a world-class scientific team led by CSO Linyu Shi and supported by a strong Scientific Advisory Board including Hui Yang. Our commitment to advancing genome-editing medicine is transforming the future of treatment for life-threatening conditions.

Ad Hoc Scientific Private Limited is a rapidly growing chromatography column manufacturer based in Secunderabad, Telangana, India.

We specialize in the design and production of high-performance liquid chromatography (HPLC) columns, including analytical and preparative columns, catering to a diverse range of industries including biotechnology, pharmaceuticals, and research.

Ad Hoc Scientific distinguishes itself through a commitment to customized solutions, expert method development support, and regulatory readiness, ensuring our clients achieve optimal results and streamline their workflows. We pride ourselves on our multi-disciplinary team, combining chromatography, mass spectrometry, purification, and regulatory expertise to deliver unparalleled service and performance.

Founded in 2018, Ad Hoc Scientific is dedicated to innovation and quality, providing reliable and cost-effective chromatography solutions to meet the evolving needs of our global customer base.

Kemwell Biopharma is a leading, fully integrated biologics CDMO based in Bangalore, India, specializing in contract development and manufacturing services for global biopharmaceutical organizations.

We support the entire lifecycle of protein therapeutics, from preclinical development through commercial manufacturing, offering a comprehensive suite of services including bioprocessing excellence, process development, formulation development, analytical development, and quality control.

With over 60 years of experience and a strong track record of successful collaborations with major pharmaceutical companies – including Bayer, GlaxoSmithKline, and Pfizer – Kemwell leverages cutting-edge technology and a highly skilled team to deliver cost-effective and time-efficient solutions. Our commitment to quality and regulatory compliance, evidenced by numerous audits and approvals, ensures our clients receive reliable and scalable manufacturing support.

Kemwell is proud to be one of Asia’s best biologics CDMOs, offering flexible and quick turnarounds, and is licensed to manufacture commercial Drug Substance and Drug Product in countries across CIS, Southeast Asia, and the Middle East.

BGG is a leading global supplier of high-quality, clinically-validated natural ingredients, headquartered in Beijing, China.

We specialize in the development and purification of active plant extracts for the dietary supplement, pharmaceutical, personal care, and food & beverage industries. Since 1995, BGG has cultivated a reputation for excellence, sourcing premium and non-GMO raw materials from around the world.

BGG distinguishes itself through its commitment to rigorous quality control, backed by extensive research and clinical studies, including those validating ApplePhenon’s benefits for metabolic syndrome and seasonal allergies. Our global network of production sites and dedicated team ensure consistent supply and technical support to our clients worldwide.

We offer a diverse portfolio of ingredients, including AstaZine®, ApplePhenon®, TheraPrimeE®, MyrtiPRO®, ThinOGen®, and Licorice-based products, alongside innovative solutions like Steviol glycosides and Enoxolone. BGG is ISO9001, ISO22000 and GMP certified.

We are a Consumer Neurotech start-up focussing on Intelligent systems and devices. We are building our patent-pending state of art AI platform Zeuron.ai centred around feedback from Neurons and Muscles, which, when applied, can disrupt the markets in various consumer segments. Our segments range from Deeptech research, Diseases Management, Rare Diseases, Mental Health, Gaming and many more. Zeuron.ai is a platform for consumers, researchers, hobbyists and developers to tap the potential of Neurotechnology. We will also be launching our Medical Devices in neurodegenerative segments encompassing diseases like Parkinson's, Neuropathy, Muscular Dystrophy etc. Do keep looking out for more exciting news and announcements in the coming days: http://zeuron.ai Do write in case of any interest to partner, collaborating or working with us: hello@zeuron.ai

Briota is an award winning MedTech company committed to innovating tech solutions for remote care, diagnostics and management for chronic respiratory conditions. Briota was established in February 2018 with a mission of democratization of lung health solutions for patients with moderate to severe asthma and COPD conditions. Our AI first approach aims to simplify the diagnostics and lifecycle management of Chronic Respiratory Ailments in a post Covid-19 world. Briota’s innovative work in Prioritizing Care for Covid 19 patients using power of AI and ML has helped reduce Case Fatality Rate in patients with comorbidities. Government of India – Department of Science, BIRAC and Technology Development Board has funded R&D work of Briota. Briota’s Covid 19 Home Management service has benefitted over 15000 patients in Mumbai and currently is in implementation for over 40,000 workmen colony members in Tier II and Tier III cities like Renukoot, Hirakud, Utkal etc.

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.

AgriGenome Labs (AgGenome) was started in 2013 as a division of SciGenom Labs and after successful incubation, it became an independent company in 2015 with facilities in Genome Valley, Hyderabad and "SmartCity Kochi", Cochin. Both the facilities are equipped with state-of-the-art instruments and provide genome sequencing, editing and bioinformatics services for Plant, Animal & Microbial projects of the industry as well as academic and government institutions. AgGenome genomics platforms include PacBio Sequel (first installation in Asia), Illumina sequencers, ABI 3730xl Sanger sequencers and more. AgGenome genomics platoforms include PacBio Sequel (first installation in Asia), Illumina sequencers, ABI 3730xl Sanger and more.

Socium is AI-driven drug discovery biotech predicts the correlation between drugs and diseases based on gene expression. Our innovative AI platform is capable of finding new additional indications for YOUR compound in clinical phase 2 or 3. Especially orphan disease and intractable diseases including cancers. In addition, the company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months.

SMACgig WORLD ( Sense, Measure, Analyze and Control) The vision of SMACgig WORLD( Sense, Measure, Analyze and Control) is to disrupt the way the distribution is done. Conventional distribution was characterised by a set of physical interventions at different levels between manufacturers till the end-user. With the advent of IT, Social media and Digital communication in different hues, brands have started to communicate with the consumers directly and the communication has become two-way, instantaneous and seamless. There is a need to re imagine, redefine and reconfigure the physical interventions alongside the seamless digital journeys. We either have large organizations chartering digitalization of their own journeys covering all their value chains or SMEs struggling to understand how to chart their own digital journeys through individual SaaS application Tools for different workflows or through PaaS platforms. Irrespective of the direction, SMEs have very high defits of knowledge and scale of operation. In addition, the world is moving towards a data economy with advancements in data science,ML( Machine learning). DL ( Deep Learning) and AI Artificial Intelligence). We can not be left behind. With companies rushing behind MDM (Master data management) CDP (Customer data platforms) and integrated Marcom( Marketing Communication platforms with associated data analytics. We need to make our own initial steps. SMACgig WORLD is a knowledge hub to attract, engage and delight all stakeholders to seamlessly create collaborative wealth for all before creating economic wealth with commercial transactions.. With our outside-in approach through knowledge based customer engagement, sustenance of customer interest with personalized assistance & support and ultimately achieve customer success by catering to the 360° customer needs. Its an amalgamation pot for MANUFACTURER, DEALER, APPLICATION EXPERTS and TECHNICAL SERVICES to blend and create a magic.

Ultreze Enzymes uses its expertise in enzyme manufacturing to supply customers enzymes like pharmaceutical enzymes, food enzymes, animal feed enzymes, sugar processing enzymes, distillery processing enzymes, starch processing enzymes and for many various industries.

Cordlife is Asia's largest private Stem Cell Banking Network. Trusted by more than 6 lacs parents, it is internationally accredited by AABB, WHO GMP, CAP and is currently present in 10 countries. Cordlife India is a fully-owned subsidiary of Cordlife Group Limited, a company listed on the Singapore Stock Exchange. A winner of Technology Pioneer award conferred by the World Economic Forum, Cordlife has accumulated more than 21 years of experience in stem cell processing and cryopreservation.

MICROLIT, a product IP firm headquartered in Lucknow, was co-conceptualised by Mr. Ajay Jain and Mr. Atul Jain, and formally established in the year 1991. The firm designs and develops high precision liquid handling instruments for leading biotechnology and pharmaceutical laboratories of the world. Its product range includes Bottle Top Dispensers, Micropipettes, E-Burettes, pipettes and pipette filling devices including accessories like stands and tips for Micropipettes. With offices in India, USA (https://www.microlit.us) and Brazil, the firm has steadily garnered the trust of its consumers situated in 65 countries, who recognize it as a respected and dependable brand in the healthcare and life sciences industry worldwide.

Anhui Sealong Biobased Industrial Technology Co.,Ltd is a manufacturer and supplier of 100% biodegradable Products and compostable Resin, including biodegradable plastic bags, shopping bags, garbage bags, food waste bags,Fruit vegetable bags,tea coffee bags, pet waste bags, etc.

Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Our goal is to have at least one antibody to every human expressed gene in human genome. In Phase I of our business plans, we vastly expand the scope and availability of antibody reagents for the research market by taking a genome-wide approach to the high throughput production of human protein and antibody. There products are marketed through a combination of E-commerce based direct sales and a multi-tiered, sales network of over 49 distributors around the world. Starting from Year 2009 to 2013, in Phase II of the business plans, we have diversified into the systems arena focusing on antibody pairs, ELISA kits and instrumentation for rare cell isolation. In Phase III, we focus on in vitro diagnostics development concentrating on non-invasive, liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Now in Phase IV (Year 2017 and later), we have focused on drug development specializing on immunotherapy. The value-added business has set the path of company's future growth and provided opportunity for Abnova to contribute to the biotech industry at large. We welcome researchers, biotech, and pharmaceutical companies to work with us and succeed together!

MiCroBial Technologies create a powerful composite biocatalyst from a unique blend of microorganisms, enzymes, and co-factors. This composite biocatalyst co-exists with existing wastewater biology to enhance their rate of reaction, resulting in a more efficient biological treatment process. The technology fits into a relatively new scientific field called Bioaugmentation that presents a simple and cost effective way to solve wastewater treatment, solid waste treatment, aquaculture problems without expensive capital enhancements. Unique to MiCroBial technologies is the ability to reduce the required time for bacteria to adapt to new waste streams. MiCroBial technologies enables a rapid biological response to load and flow variation, a key differentiator to conventional Bioaugmentation which rely on product formulations specific to a waste stream. MiCroBial Technologies provide variety of microbiological products for different problems wastewater treatment so that clients can achieve their pollution norms.

Mylab is a health-tech company that develops & commercialises molecular diagnostic kits and instruments to empower labs in obtaining Reliable, Timely & Actionable answers. We are a company driven by Science and Technology , and our goal is to outpace others in delivering high-quality healthcare solutions to improve lives. What makes Mylab a perfect choice is the power of certainty, providing insights, support, expertise, services, and solutions with an indispensable share. As a leader in providing high-end healthcare solution, we believe it is our duty to be at the forefront of disease control and clinical management.

Eagle Seeds was founded in 1982 in a small town Alote in Central India. Within a short span, it has emerged as a pioneer in the field of Soybean, Wheat and Vegetable seeds and the "Eagle"​ brand today is considered as one of the most recognized and respected seed brands in the country. We have successfully traveled through challenging times and reached new horizons. After gaining repute and experience in the field of seed crops, we plan to foray into the field of biotech research. Our mission is to exploit the potential areas in biotechnology for the benefit and prosperity of the Indian farmer. With a history that spans over a few decades, you can count on Eagle Seeds'​ experience and stability to help you succeed in today's challenging agricultural environment. Eagle Seeds'​ state-of-the-art research capabilities have enabled growers to provide quality seeds and many new varieties over the few years. This dedication to be progressive and innovative continues till today. The company has a sales network, production facilities, field testing sites, and product lines that span over the major states in India. We have got the best of manufacturing, processing and storage facilities that meet the international standards. With skilled staff, the company is capable of rendering top-notch services to all the clients and growers. The experience of Indian conditions enables us to give you products that are unique to your region's conditions. We are able to assist you throughout the growing season no matter where you farm. Eagle Seeds'​ heritage, combined with its technology and research, makes it your best bet for quality seed and technical support.

TPISTOS is a Gujarat, India-based global supply chain and consulting partner specializing in in vitro study solutions for the pharmaceutical, biotech, and healthcare sectors.

We empower researchers and innovators by delivering comprehensive support, from sourcing high-quality, USFDA- and CE-certified components like feeding tubes and syringes, to providing expert regulatory consulting for IVRT, IVPT, and BCS-based biowaiver studies.

Our strategic outsourcing services streamline study-to-submission journeys, offering end-to-end execution support, vendor coordination, and compliance-driven logistics. We’re dedicated to accelerating your research and development goals with precision and reliability.

BioBrain Pro is an Armenian-based clinical research organization (CRO) specializing in providing comprehensive solutions to the pharmaceutical, biotechnology, and medical device industries.

We support our clients through every phase of their clinical trials, from initial study design and protocol development to site selection, patient recruitment, data management, and regulatory compliance.

BioBrain Pro leverages innovative approaches, including adaptive trial design and the integration of advanced technologies like AI and machine learning, to optimize trial outcomes and reduce costs. Our team of experienced professionals delivers personalized attention and ensures precision in every phase of the clinical research process.

Founded in 2018, BioBrain Pro has rapidly grown to a team of 37, with a growing presence in the United States, offering a reliable and cutting-edge partner for complex clinical trials.

TCRCure Biopharma Corp is a leading cell therapy biopharmaceutical company based in Guangzhou, China, dedicated to transforming cancer treatment.

We specialize in the innovation, development, and clinical translation of cutting-edge cellular immunotherapies, primarily targeting solid tumors. Leveraging our proprietary ASPIRET, ARMORS, and TRUST platforms – including a next-generation T cell therapy platform, an advanced cell armoring platform, and an AI-powered high-throughput TCR discovery platform – we are advancing eight pipelines across multiple cancer types.

Our team, comprised of industry pioneers in cell therapy, is united by a mission to make patient-driven cellular immunotherapy innovation a reality, ultimately aiming to transform cancer into a manageable condition and achieve a cure. We operate facilities in the United States (Durham, NC & Los Angeles, CA) and China (Guangzhou, Chongqing, Hong Kong).

Founded in 2009, Beyond Biopharma Co., Ltd. is an ISO 9001 Verified and US FDA Registered manufacturer of collagen bulk powder and gelatin series products located in China. The production facility covers 9000 square meters with 4 dedicated advanced automatic production lines, HACCP workshop of 5500㎡ and GMP workshop of 2000㎡, with annual production capacity of 3000MT Collagen bulk Powder and 5000MT Gelatin series Products, exported to around 50 countries worldwide.

Bioscan Research aims to improve traumatic brain injury patient outcomes via an objective assessment for early detection at a pre-symptomatic phase with the help of machine learning powered NIRS device - CEREBO.

We perform Antibody Discovery using Artificial Intelligence. Job Openings: https://www.immunitoai.com/job-openings Our Team: https://www.immunitoai.com/about-us YouTube Channel: https://www.youtube.com/@immunitoAI

We are the manufacturer of Rapid test kits, RTPCR test kits and Biochemistry reagents.

Look at Gel Documentation – the new Vü Pop Bio has developed an exciting new system for the image capture and analysis of gels and blots. The innovative Vü imaging system opens up a new era for gel documentation. Vü Imaging is no ordinary gel documentation system however. The Pop Bio Vü Imaging system uses no cameras, no lenses, filters, or lasers but instead utilizes a new technology to accurately map images at ultra-high sensitivity and resolution. The result is a small desk top instrument with a very small footprint that can handle the full range of gel and blot applications – UV, blue light, visible and chemiluminescence. The Advanced Progressive Imaging technology, which was developed in Cambridge, is a clever use of imaging sensors that accurately map low levels of light from any gel or blot. A patent for this new technology has been applied for. Aside from the new technology being used in the instrument the cost is also considerably lower than that of a traditional gel documentation system which uses high cost CCD cameras, lenses and filters. The Pop Bio Vü Imaging system aims to become the new standard for gel and blot image capture and replace existing traditional gel documentation systems over the next few years. This device is destined to change the way images of gels and blots are captured. Two variants of the instrument have been launched. The Vü-F is for fluorescence applications like Etbr DNA gels using UV or safe dyes using blue light as well as visible light protein gels and blots. The Vü-C has increased sensitivity for chemiluminescent western blots. The Pop Bio's Imaging division is dedicated to the development of innovative imaging solutions for the scientific community.

AMS (Pvt) Ltd. is a Pakistan based company, actively involved in marketing of Analytical / Life Science Instruments of highest repute. AMS (Pvt.) Ltd. Represents in Pakistan few of the world’s largest developers and manufacturers of Biotechnology, Analytical and Nanotechnology instruments. With over 2,000 major installations in Pakistan. We have a very large customer base among public and private sector organizations in Pakistan. By, far we are the largest company in our field in Pakistan. Our customers include petroleum, mining, pharmaceutical, environment, tanneries, armed forces, research organizations, scientists, hospitals, universities and foreign funded projects. All this is of-course possible through a team of very active and unbeatable sales and service group called as AMS. AMS have successfully supplied, installed and is now providing back-up services to diverse range of high tech. instruments which includes Electron Microscopes, Gas/Liquid Chromatographs, Atomic Absorption Spectrometers, UV/Vis Spectrophotometers, DNA Synthesizers, Genetic Analysis Systems, Automated Protein Sequencers, and Petroleum Testing Equipments etc. The company is staffed by some of the best people of their field available in the country. AMS corporate headquarter is in Karachi with major branch offices in Islamabad, Lahore and Peshawar.

Northeast Thailand or ISAN levels up its significance with strategic location to 6 countries in the Greater Mekong Sub-region (GMS) namely, Cambodia, China Laos, Myanmar, Vietnam, Thailand. As Thailand’s largest agricultural area based producer, ISAN now refocuses to become the new destination of biotechnology investment and Bio-Circular-Green (BCG) new economy development of GMS and Asia.

Arlak Biotech Pvt. Ltd. is a professionally managed pharmaceutical company, aim to become a top pharmaceutical company. Arlak Biotech has established a strong presence in the pharmaceutical industry with an extensive range of healthcare products at the most affordable prices. Arlak Biotech markets over 2,500+ brands for various human medical needs and is the Best PCD Pharma Company in India.

Jubilant Biosys offers comprehensive Chemistry Services including medicinal chemistry, synthetic chemistry, and process development. Our expert scientists deliver innovative solutions to accelerate drug discovery and development. With state-of-the-art infrastructure and global standards, we provide customized chemistry support for pharmaceutical and biotech companies across early discovery to clinical stages.